Harrow, Inc. (HROW)

47.48 +0.16 (+0.35%) USD  |  NASDAQ  |  Feb 09, 16:00
47.40 -0.08 (-0.18%) After-Hours: 20:00
More

Harrow Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for HROW.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Corcept Therapeutics, Inc. Upgrade
Assertio Holdings, Inc. Upgrade
Skye Bioscience, Inc. --
Theravance Biopharma, Inc. Upgrade
Kyntra Bio, Inc. Upgrade